Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

The Value of Averageness in Aesthetic Rhinoplasty: Humans Like Average Noses.

van Zijl FVWJ, Perrett DI, Lohuis PJFM, Touw CE, Xiao D, Datema FR.

Aesthet Surg J. 2020 Jan 21. pii: sjaa010. doi: 10.1093/asj/sjaa010. [Epub ahead of print]

PMID:
31960890
2.

Evaluation of Measurement Properties of Patient-Reported Outcome Measures After Rhinoplasty: A Systematic Review.

van Zijl FVWJ, Mokkink LB, Haagsma JA, Datema FR.

JAMA Facial Plast Surg. 2019 Mar 1;21(2):152-162. doi: 10.1001/jamafacial.2018.1639.

PMID:
30605215
3.

Use of Routine Prospective Functional and Aesthetic Patient Satisfaction Measurements in Secondary Cleft Lip Rhinoplasty.

van Zijl FVWJ, Versnel S, van der Poel EF, Baatenburg de Jong RJ, Datema FR.

JAMA Facial Plast Surg. 2018 Dec 1;20(6):488-494. doi: 10.1001/jamafacial.2018.0876.

4.

Surgical management of inverted papilloma; a single-center analysis of 247 patients with long follow-up.

Bugter O, Monserez DA, van Zijl FVWJ, Baatenburg de Jong RJ, Hardillo JA.

J Otolaryngol Head Neck Surg. 2017 Dec 20;46(1):67. doi: 10.1186/s40463-017-0246-7. Review.

5.

Transparency in Functional Rhinoplasty: Benefits of Routine Prospective Outcome Measurements in a Tertiary Referral Center.

Datema FR, van Zijl FVWJ, van der Poel EF, Baatenburg de Jong RJ, Lohuis PJFM.

Plast Reconstr Surg. 2017 Oct;140(4):691-702. doi: 10.1097/PRS.0000000000003701.

PMID:
28953719
6.

Adaptation and validation of the Dutch version of the nasal obstruction symptom evaluation (NOSE) scale.

van Zijl FVWJ, Timman R, Datema FR.

Eur Arch Otorhinolaryngol. 2017 Jun;274(6):2469-2476. doi: 10.1007/s00405-017-4486-y. Epub 2017 Mar 3.

7.

Postoperative value of serum squamous cell carcinoma antigen as a predictor of recurrence in sinonasal inverted papilloma.

van Zijl FVWJ, Monserez DA, Korevaar TIM, Bugter O, Wieringa MH, Baatenburg de Jong RJ, Hardillo JAU.

Clin Otolaryngol. 2017 Jun;42(3):528-535. doi: 10.1111/coa.12757. Epub 2016 Oct 16.

PMID:
27717197
8.

Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma.

Reichl P, Dengler M, van Zijl F, Huber H, Führlinger G, Reichel C, Sieghart W, Peck-Radosavljevic M, Grubinger M, Mikulits W.

Hepatology. 2015 Mar;61(3):930-41. doi: 10.1002/hep.27492. Epub 2015 Jan 28.

9.

Initial steps of metastasis: cell invasion and endothelial transmigration.

van Zijl F, Krupitza G, Mikulits W.

Mutat Res. 2011 Jul-Oct;728(1-2):23-34. doi: 10.1016/j.mrrev.2011.05.002. Epub 2011 May 12. Review.

10.

p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma.

Schneller D, Machat G, Sousek A, Proell V, van Zijl F, Zulehner G, Huber H, Mair M, Muellner MK, Nijman SM, Eferl R, Moriggl R, Mikulits W.

Hepatology. 2011 Jul;54(1):164-72. doi: 10.1002/hep.24329.

PMID:
21452288
11.

A human model of epithelial to mesenchymal transition to monitor drug efficacy in hepatocellular carcinoma progression.

van Zijl F, Mall S, Machat G, Pirker C, Zeillinger R, Weinhaeusel A, Bilban M, Berger W, Mikulits W.

Mol Cancer Ther. 2011 May;10(5):850-60. doi: 10.1158/1535-7163.MCT-10-0917. Epub 2011 Mar 1.

12.

Hepatospheres: Three dimensional cell cultures resemble physiological conditions of the liver.

van Zijl F, Mikulits W.

World J Hepatol. 2010 Jan 27;2(1):1-7. doi: 10.4254/wjh.v2.i1.1.

13.

Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis.

Blaas L, Kornfeld JW, Schramek D, Musteanu M, Zollner G, Gumhold J, van Zijl F, Schneller D, Esterbauer H, Egger G, Mair M, Kenner L, Mikulits W, Eferl R, Moriggl R, Penninger J, Trauner M, Casanova E.

Hepatology. 2010 Apr;51(4):1319-26. doi: 10.1002/hep.23469.

14.

Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence.

Zulehner G, Mikula M, Schneller D, van Zijl F, Huber H, Sieghart W, Grasl-Kraupp B, Waldhör T, Peck-Radosavljevic M, Beug H, Mikulits W.

Am J Pathol. 2010 Jan;176(1):472-81. doi: 10.2353/ajpath.2010.090300. Epub 2009 Dec 11.

15.

Epithelial-mesenchymal transition in hepatocellular carcinoma.

van Zijl F, Zulehner G, Petz M, Schneller D, Kornauth C, Hau M, Machat G, Grubinger M, Huber H, Mikulits W.

Future Oncol. 2009 Oct;5(8):1169-79. doi: 10.2217/fon.09.91. Review.

16.

Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge.

van Zijl F, Mair M, Csiszar A, Schneller D, Zulehner G, Huber H, Eferl R, Beug H, Dolznig H, Mikulits W.

Oncogene. 2009 Nov 12;28(45):4022-33. doi: 10.1038/onc.2009.253. Epub 2009 Aug 31.

17.

ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression.

Lahsnig C, Mikula M, Petz M, Zulehner G, Schneller D, van Zijl F, Huber H, Csiszar A, Beug H, Mikulits W.

Oncogene. 2009 Feb 5;28(5):638-50. doi: 10.1038/onc.2008.418. Epub 2008 Nov 17.

18.
19.

Transhepatic intubation of the common bile duct for inoperable obstruction--experience with 20 cases.

Heydenrych JJ, van Zijl FD, van Zyl JJ.

J Surg Oncol. 1969;1(1):63-75. No abstract available.

PMID:
4107044
20.

A primate research colony: the Stellenbosch-Johns Hopkins Baboon Facility.

de Klerk JN, van Zyl JJ, Brede HD, Weber HW, van Zyl JA, van Zijl FD, Brink AJ, Murphy GP, Scott WW, Melby EC.

S Afr Med J. 1968 May 11;42(19):459-62. No abstract available.

PMID:
4967923
21.

[Achievements of the medical faculty of the University of Stellenbosch].

van ZIJL F.

S Afr Med J. 1960 May 21;34:425-6. Afrikaans. No abstract available.

PMID:
13847468
22.

Views on the treatment of carcinoma of the breast.

VAN ZIJL FD.

S Afr Med J. 1958 Aug 16;32(33):827-9. No abstract available.

PMID:
13580485

Supplemental Content

Loading ...
Support Center